Medtronic plc (MDT) Earnings Per Share (EPS): 3.73
Is Medtronic plc’s earnings per share (EPS) high or low?
Medtronic plc's earnings per share (EPS) of 3.73 is 15% above its 5-year average of 3.23, near the high end of its 5-year range (2.68–3.75).
As of Friday, June 12, 2026. 1.08% above its 12-month average of 3.69.
MDT Earnings Per Share (EPS) Chart
MDT Average Earnings Per Share (EPS) Chart
MDT Current vs Average Earnings Per Share (EPS) Chart
MDT Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
3.73
EARNINGS PER SHARE (EPS) AVG TTM
3.69
EARNINGS PER SHARE (EPS) AVG 3Y
3.25
EARNINGS PER SHARE (EPS) AVG 5Y
3.23
EARNINGS PER SHARE (EPS) AVG 10Y
3.10
EARNINGS PER SHARE (EPS) AVG 15Y
3.08
EARNINGS PER SHARE (EPS) AVG 20Y
2.88
CURRENT VS TTM AVG
+1.08%
CURRENT VS 3Y AVG
+14.95%
CURRENT VS 5Y AVG
+15.30%
CURRENT VS 10Y AVG
+20.18%
CURRENT VS 15Y AVG
+20.96%
CURRENT VS 20Y AVG
+29.45%
MDT Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medtronic plc (MDT) | $103.17B | 3.73 | 3.69 | 3.25 | 3.23 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $112.95B | 16.86 | 6.69 | 10.10 | 9.99 |
| Bristol-Myers Squibb Company (BMY) | $116.19B | 3.56 | -0.48 | 1.47 | 0.84 |
| Elevance Health Inc. (ELV) | $86.69B | 23.51 | 25.49 | 25.23 | 24.07 |
| Cigna Corporation (CI) | $78.38B | 23.58 | 17.27 | 18.45 | 18.81 |
| Danaher Corporation (DHR) | $128.27B | 5.17 | 5.20 | 6.66 | 6.73 |
| CVS Health Corporation (CVS) | $129.25B | 2.27 | 2.53 | 3.71 | 4.39 |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.00B | 41.04 | 41.98 | 40.38 | 45.10 |
| Intuitive Surgical, Inc. (ISRG) | $146.23B | 8.25 | 7.27 | 5.84 | 5.20 |
| Pfizer Inc. (PFE) | $149.18B | 1.31 | 1.39 | 2.19 | 2.39 |
EPS Comparison
Trailing EPS (TTM)
$3.73
Forward EPS (Est.)
$6.38
P/E Ratio
21.5
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
Medtronic plc Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medtronic plc Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for Medtronic plc (MDT)?
- The earnings per share (EPS) for MDT stock is 3.73.
- Is Medtronic plc's earnings per share (EPS) high or low?
- Medtronic plc's earnings per share (EPS) of 3.73 is 15% above its 5-year average of 3.23, near the high end of its 5-year range (2.68–3.75).
- What is the TTM average earnings per share (EPS) for Medtronic plc (MDT)?
- The TTM average earnings per share (EPS) for MDT stock is 3.69.
- What is the 3Y average earnings per share (EPS) for Medtronic plc (MDT)?
- The 3Y average earnings per share (EPS) for MDT stock is 3.25.
- What is the 5Y average earnings per share (EPS) for Medtronic plc (MDT)?
- The 5Y average earnings per share (EPS) for MDT stock is 3.23.
- What is the 10Y average earnings per share (EPS) for Medtronic plc (MDT)?
- The 10Y average earnings per share (EPS) for MDT stock is 3.10.
- What is the 15Y average earnings per share (EPS) for Medtronic plc (MDT)?
- The 15Y average earnings per share (EPS) for MDT stock is 3.08.
- What is the 20Y average earnings per share (EPS) for Medtronic plc (MDT)?
- The 20Y average earnings per share (EPS) for MDT stock is 2.88.
Medtronic plc Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-04-24 | 3.75 |
| 2025-04-30 | 3.63 |
| 2024-04-30 | 2.77 |
| 2023-04-30 | 2.83 |
| 2022-04-30 | 3.75 |
| 2021-04-30 | 2.68 |
| 2020-04-30 | 3.57 |
| 2019-04-30 | 3.44 |
| 2018-04-30 | 2.29 |
| 2017-04-30 | 2.92 |
| 2016-04-30 | 2.51 |
| 2015-04-30 | 2.44 |
| 2014-04-30 | 3.06 |
| 2013-04-30 | 3.40 |
| 2012-04-30 | 3.43 |
| 2011-04-30 | 2.87 |
| 2010-04-30 | 2.80 |
| 2009-04-30 | 1.85 |
| 2008-04-30 | 1.97 |
| 2007-04-30 | 2.44 |
| 2006-04-30 | 2.11 |
| 2005-04-30 | 1.49 |
| 2004-04-30 | 1.61 |
| 2003-04-30 | 1.31 |
| 2002-04-30 | 0.81 |
| 2001-04-30 | 0.87 |
| 2000-04-30 | 0.91 |
| 1999-04-30 | 0.40 |
| 1998-04-30 | 0.52 |
| 1997-04-30 | 0.51 |
Related Metrics
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Geoffrey Straub Martha